Ratings by Wells Fargo (Derek Archila )
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/14/2024 | MorphoSys AG | MOR | Downgrade | Equal Weight (Overweight) |
18.04 (18.96) |
5.1% | Details | |
| 12/19/2023 | Kymera Therapeutics | KYMR | Downgrade | Equal Weight (Overweight) |
25.29 (83.49) |
230.13% | Details | |
| 11/7/2023 | Ventyx Biosciences Inc | VTYX | Downgrade | Equal Weight (Overweight) |
15.58 (14.00) |
-10.14% | Details |
